0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Reviews |

Oral Corticosteroid Therapy for Patients with Stable Chronic Obstructive Pulmonary Disease: A Meta-Analysis

Christopher M. Callahan, MD; Robert S. Dittus, MD, MPH; and Barry P. Katz, PhD
[+] Article and Author Information

Grant Support: In part by grant D28 PE-55009 from the Bureau of Health Professions, Health Resources and Services Administration, and by Institutional NRSA award PHS T32 PE15001 from the National Institutes of Health. Dr. Dittus was partially supported by an American College of Physicians' Teaching and Research Scholar Award.

Requests for Reprints: C. M. Callahan, MD, Indiana University School of Medicine, Department of Medicine, Regens trief Health Center, 5th Floor, 1001 West 10th Street, Indianapolis, IN 46202-2859.

Current Author Addresses: Drs. Callahan and Dittus: Indiana University School of Medicine, Department of Medicine, Regenstrief Health Center, 5th Floor, 1001 West 10th Street, Indianapolis, IN 46202-2859.

Dr. Katz: Indiana University School of Medicine, Division of Biostatistics, Riley Hospital for Children, 702 Barnhill Drive, RR 135, Indianapolis, IN 46202-5200.


Ann Intern Med. 1991;114(3):216-223. doi:10.7326/0003-4819-114-3-216
Text Size: A A A

Purpose: To evaluate the effectiveness of oral corticosteroid therapy in patients with stable chronic obstructive pulmonary disease.

Data Identification: An English-language literature search using MEDLINE (1966 to 1989) and a bibliographic review of all retrieved articles identified 33 original studies of oral corticosteroid use in chronic obstructive pulmonary disease published since 1951.

Study Selection: We submitted a photocopy of each study's "methods" section to three nonstudy physician-investigators who used nine explicit criteria to independently assess study quality. Ten studies met all criteria and five studies met some of the criteria.

Data Extraction: To compare outcomes across all qualifying studies, we defined response to therapy as a 20% or greater increase in the baseline forced expiratory volume in 1 second (FEV1); we defined the treatment effect size for each study as the proportion of patients who responded to corticosteroid therapy minus the proportion of patients who responded to placebo. Potential confounding variables as related to eligibility criteria and treatment protocols were also assessed for each study.

Results of Data Synthesis: Among ten studies that met all nine criteria, we found no significant differences in eligibility criteria, treatment protocol, or study design. No association was found between treatment effect size and publication date, study size, mean patient age, or FEV1. These studies had reported effect sizes ranging from 0% to 56%; we calculated a weighted mean effect size of 10% (95% CI, 2% to 18%). When studies meeting only some of the criteria were included in the calculation, the weighted mean effect size was 11% (95% CI, 4% to 18%).

Conclusions: Patients with stable chronic obstructive pulmonary disease receiving oral corticosteroid therapy have a 20% or greater improvement in baseline FEV1 approximately 10% more often than similar patients receiving placebo.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)